Cronos Group

What Canada’s top CEOs say about cannabis ‘commoditization’

While a shortage of marijuana is expected to precede any glut by a number of years, the potential for cannabis commoditization is already a consideration for many licensed cultivators in Canada. Greg Engel, CEO of New Brunswick-based Organigram, said commoditization, at least as it relates to cannabis, boils down to two things: Excess supply over […]

Read More

Canopy seeks to become first marijuana producer traded on New York Stock Exchange

Canada’s market leader in medical marijuana has applied to trade its shares on the New York Stock Exchange, a move that would make it the first cannabis-producing company to list on the world’s largest stock market.

Smiths Falls, Ontario-based Canopy Growth said in a news release it expects its shares to begin trading on the NYSE “before the end of May” under the symbol CGC.

Read More

Canadian Senate committee asks for marijuana legalization delay

Two Senate committees reviewing Canada’s proposed marijuana legislation are asking for significant changes to the bill before it becomes law – changes that could delay implementation and have a major impact on businesses prepping for the recreational market.

The Committee on Aboriginal Peoples wants the bill amended to address a “lack of meaningful consultation” with First Nations communities and asked for a delay of up to one year.

Read More

US-focused marijuana company agrees to purchase Canadian grower

A Toronto-based marijuana company focused on U.S. recreational and medical cannabis markets plans to spend about 23 million Canadian dollars ($18.3 million) in cash, stock and warrants to acquire a small licensed producer in Ontario. MPX Bioceutical agreed to acquire Peterborough-based Canveda for CA$3 million in cash, CA$15 million in stock plus the issuance of 6 […]

Read More

Aurora to build Alberta marijuana production facility with eye on exports

One of Canada’s top licensed producers unveiled plans for its largest cultivation facility, with a “significant proportion” of the new production slated to address a “massive” supply shortfall for medical cannabis overseas. Aurora Cannabis plans to build the 1.2-million-square-foot facility in Medicine Hat, Alberta, to take advantage of the “sunniest city in Canada” and save […]

Read More

Canada’s cannabis oil exports rise 300%, boosted by German demand

Exports of medical cannabis oil from Canada had a breakout year in 2017 – and executives say it is just the start for a massive new overseas market.

Medical cannabis exports in oil form rose 300% from 2016 levels, according to data shared with Marijuana Business Daily by Health Canada. Analysts expect this trend to continue as countries legalizing medical cannabis look to imports to meet demand in lieu of domestic cultivation.

Read More

Canadian cannabis firms raise CA$2 billion to fuel growth

Canada’s medical cannabis companies have raised 2 billion Canadian dollars ($1.57 billion) in capital this year to tap overseas opportunities and build out domestic capacity ahead of legalization. While independent investment banks were involved in most of the transactions, the Bank of Montreal, through its subsidiary BMO Capital Markets, became the first major bank to lead […]

Read More

Big Canadian banks warming to legal marijuana industry

The chief executive of one of Canada’s largest banks said it would weigh financing cannabis companies after legalization takes place later this summer. TD Bank CEO Bharat Masrani said the Toronto-based financial institution is studying the issue, and any potential clients in the cannabis industry should have a presence only in countries where recreational or […]

Read More